[3] Aronne, L
For many people in the UK considering Mounjaro (tirzepatide) or Wegovy (semaglutide), the question is not just whether short-term use is possible - it is whether it is worth it
Trials so far have shown superiority of GLP-1 receptor agonists and SGLT2 inhibitors in MACE reduction when compared to DPP-4 inhibitors
But the aggressive fragrance takes away from the experience and makes it harder to recommend, especially to the people it's supposedly designed for
If you want weight management using semaglutide, Wegovy is the correct licensed product and is available at Slinic from 99.99/pen
Recently, it has been recognised that gastric emptying, even when normal, is a major, and hitherto generally underappreciated, determinant of the magnitude of the postprandial rise in blood glucose, which, in many individuals with diabetes, predominates over fasting blood glucose in determining average glycaemic control as assessed by HbA 1c